Commentary in the Journal of Neuromuscular Diseases provides an independent, unbiased assessment of the body of research on vamorolone Peer-Reviewed Publication IOS PRESS The drug vamorolone (Agamree®) has been hailed as a promising new drug to treat Duchenne muscular dystrophy (DMD). It has recently been approved for clinical use in the United States by the...